Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 17.24% is in line with its 5-year average of 16.06%, around the middle of its 5-year range (10.99%–22.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.04% below its 12-month average of 19.38%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 17.24%.
DEBT TO ASSETS RATIO
17.24%
DEBT TO ASSETS RATIO AVG TTM
19.38%
DEBT TO ASSETS RATIO AVG 3Y
17.31%
DEBT TO ASSETS RATIO AVG 5Y
16.06%
DEBT TO ASSETS RATIO AVG 10Y
9.29%
DEBT TO ASSETS RATIO AVG 15Y
9.22%
DEBT TO ASSETS RATIO AVG 20Y
48.73%
CURRENT VS TTM AVG
-11.04%
CURRENT VS 3Y AVG
-0.36%
CURRENT VS 5Y AVG
+7.33%
CURRENT VS 10Y AVG
+85.51%
CURRENT VS 15Y AVG
+87.11%
CURRENT VS 20Y AVG
-64.62%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
+17142.66%
vs the sector median at left
Aytu BioPharma, Inc.
Market Cap
$21.79M
Debt to Assets Ratio
17.24%
TTM Avg
19.38%
3Y Avg
17.31%
5Y Avg
16.06%
Market Cap
$21.07M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.96M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.85M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.61M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.71M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aytu BioPharma, Inc. (AYTU) | $21.79M | 17.24% | 19.38% | 17.31% | 16.06% |
| LeonaBio, Inc. (LONA)vs › | $21.69M | 0.01% | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $21.07M | 0.02% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.96M | 0.00% | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $19.85M | 0.20% | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.61M | 0.08% | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.29M | 0.00% | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $19.04M | 0.19% | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.71M | 0.09% | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.79M | 0.00% | N/A | N/A | N/A |
Debt/Assets
17.2%
Debt/Equity
0.51
Current Ratio
1.13
Interest Coverage
4.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 17.24% |
| 2026-03-31 | 20.54% |
| 2025-12-31 | 18.91% |
| 2025-09-30 | 21.74% |
| 2025-06-30 | 18.47% |
| 2025-03-31 | 18.13% |
| 2024-12-31 | 14.75% |
| 2024-09-30 | 15.70% |
| 2024-06-30 | 13.81% |
| 2024-03-31 | 17.46% |
| 2023-12-31 | 13.91% |
| 2023-09-30 | 12.22% |
| 2023-06-30 | 22.07% |
| 2023-03-31 | 17.05% |
| 2022-12-31 | 17.51% |
| 2022-09-30 | 17.06% |
| 2022-06-30 | 13.22% |
| 2022-03-31 | 12.59% |
| 2021-12-31 | 12.32% |
| 2021-09-30 | 10.99% |
| 2021-06-30 | 11.66% |
| 2021-03-31 | 9.88% |
| 2020-12-31 | 0.64% |
| 2020-09-30 | 1.36% |
| 2020-06-30 | 1.31% |
| 2020-03-31 | 3.15% |
| 2019-12-31 | 0.86% |
| 2019-09-30 | 1.27% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 13.39% |
| 2018-12-31 | 11.88% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.04% |
| 2015-12-31 | 20.16% |
| 2015-09-30 | 22.59% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 78.42% |
| 2014-11-30 | 286.93% |
| 2014-08-31 | 562.04% |
| 2014-05-31 | 211.37% |
| 2014-02-28 | 2007.57% |
| 2013-11-30 | 1464.98% |
| 2013-08-31 | 1029.17% |
| 2013-05-31 | 1018.35% |
| 2013-02-28 | 635.45% |
| 2012-11-30 | 701.64% |
| 2012-08-31 | 538.10% |
| 2012-05-31 | 395.18% |
| 2012-02-29 | 0.00% |
| 2011-11-30 | 318.83% |
| 2011-08-31 | 229.00% |
| 2011-05-31 | 205.41% |
| 2011-02-28 | 0.00% |
| 2010-11-30 | 200.09% |
| 2010-08-31 | 286.44% |
| 2010-05-31 | 220.84% |
| 2009-12-31 | 0.00% |
| 2009-11-30 | 202.61% |
| 2009-08-31 | 130.50% |
| 2009-05-31 | 139.21% |
| 2009-02-28 | 0.00% |
| 2008-11-30 | 92.83% |
| 2008-08-31 | 64.96% |
| 2008-05-31 | 45.67% |
| 2008-02-29 | 36.29% |
| 2007-11-30 | 32.00% |
| 2007-08-31 | 57.65% |
| 2007-05-31 | 50.86% |
